1.
|
Phase: Phase III Type: Supportive care Status: Completed Age: Over 18 Sponsor: Other Protocol IDs: CRUK-NCRI-RT-02-01, EU-20224, RIB, ISRCTN86185157, NCT00082927
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-S0307, NCCTG-SWOG-S0307, ECOG-SWOG-S0307, NSABP-SWOG-S0307, CALGB-SWOG-S0307, CAN-NCIC-SWOG-S0307, S0307, NCT00127205
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 65 and over Sponsor: Other Protocol IDs: GBG 32, BIG 4-04, NCT00196859
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 to 64 Sponsor: Other Protocol IDs: GBG 33, GAIN, NCT00196872
|
|
5.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-S0308, NCT00301886
|
|
6.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 2006-0960, NCT00824993
|
|
7.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ML20684, NCT00502736
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-S0307A, S0307A, NCT00873808
|